GPR84 and neoplasm: To eliminate the possibility that these phenotypes are caused by the impact of GPR84 on other myeloid cells, our flow cytometry studies demonstrated that the proportion of tumor-infiltrating MDSCs were not affected by deletion of Gpr84 (Supplemental 4I).